• PEAK Matrix®
    Feb. 18, 2026

    The Private Equity (PE) services market is entering a period of structural change as sponsors navigate macroeconomic volatility, selective fundraising, and heightened Limited Partner (LP) expectations around transparency, liquidity, and Environmental, Social, and Governance- (ESG)-linked performance.…
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • PEAK Matrix®
    March 09, 2026

    Software product engineering continues to be a strategic investment priority for enterprises, even as macroeconomic pressures, talent constraints, and evolving sourcing strategies reshape spending patterns. Growth is increasingly driven by AI-native product development and platform-led modernization,…
  • PEAK Matrix®
    June 02, 2025

    Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience…
  • Provider Compendium
    March 26, 2026

    Healthcare enterprises are increasingly relying on specialist IT providers to address the growing complexities of healthcare transformation, regulatory compliance, and digital innovation. Payers and providers are under pressure to modernize core systems, improve interoperability, enable digital…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • PEAK Matrix®
    Nov. 25, 2025

    Healthcare enterprises are increasingly relying on specialist IT service providers to navigate the complexities of digital transformation, regulatory shifts, and cost pressures. Mounting financial strains and evolving compliance requirements are compelling payers and providers to modernize…
  • PEAK Matrix®
    June 04, 2025

    Healthcare enterprises are increasingly recognizing the strategic value of Data, Analytics, and AI (DAAI) as data-driven decision-making becomes central to achieving business and clinical outcomes. While DAAI initiatives have traditionally focused on cost containment and operational…
  • PEAK Matrix®
    Sep. 04, 2025

    Mid-market software product engineering enterprises are experiencing strong momentum, driven by their growing ambition to innovate faster and scale smarter. The increasing reliance on technology outsourcing has accelerated their ability to move beyond minimum viable products…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • PEAK Matrix®
    Aug. 25, 2025

    Cloud services are enabling mid-market enterprises to accelerate transformation and remain resilient amid macroeconomic challenges. Unlike large enterprises, mid-market organizations prioritize agility, speed, and efficiency, placing a premium on service models that deliver faster time-to-value and…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • PEAK Matrix®
    Dec. 05, 2024

    In the past few years, enterprise adoption of technology and digitization has significantly increased, changing the landscape for healthcare providers and patients. To improve provider reimbursements, patient engagement, and care management and accelerate value-based care programs,…
  • PEAK Matrix®
    Aug. 07, 2024

    Mid-market life sciences enterprises are increasingly transforming digitally to remain agile and resilient amid global uncertainties. They face unique challenges that differ from those of larger counterparts, necessitating sourcing needs such as client intimacy, agility, and…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Provider Compendium
    June 27, 2025

    The Banking, Financial Services, and Insurance (BFSI) industry is navigating heightened economic uncertainty, rapid technology innovation, and sophisticated customer demands. In response, enterprises are turning to specialized IT services firms. These providers offer in-depth domain expertise,…
  • Technology Application Deep Dive
    April 23, 2026

    Digital Therapeutics (DTx) represent a rapidly evolving class of evidence-based interventions that leverage software as a medical device to prevent, manage, or treat medical conditions through behavioral modification, personalized feedback, and continuous data-driven support. Unlike general…
  • Provider Compendium
    Nov. 11, 2025

    Software product engineering services for mid-market enterprises are witnessing strong growth driven by their growing ambition to innovate faster and scale smarter. The increasing reliance on technology outsourcing has accelerated their ability to move beyond minimum…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…

Items per page